Concepedia

Andrew Lewin

AL

41

Publications

5.3K

Citations

24

H-Index

1971

Active since

Affiliations

National Research Institute(Current)

Boehringer Ingelheim (Germany)

Diabetes & Glandular Disease Clinic

Novo Nordisk (Denmark)

Pfizer (United States)

Andrew Lewin is an author at National Research Institute specializing in medicine, cardiovascular disease, and pharmacology.

Top concepts

Publications per year

1971–2015

41

Publications

41

Efficacy of Liraglutide for Weight Loss Among Patients With Type 2 Diabetes

Melanie J. Davies, Richard M. Bergenstal, Bruce W. Bode et al. · JAMA · 2015 · 1.1K citations · Full text

Efficacy and Safety of the Human Glucagon-Like Peptide-1 Analog Liraglutide in Combination With Metformin and Thiazolidinedione in Patients With Type 2 Diabetes (LEAD-4 Met+TZD)

Bernard Zinman, John Gerich, John B. Buse et al. · Diabetes Care · 2009 · 834 citations · Full text

Initiating Insulin Therapy in Type 2 Diabetes

Philip Raskin, Elsie Allen, Priscilla Hollander et al. · Diabetes Care · 2005 · 557 citations · Full text

Selective Aldosterone Blockade with Eplerenone Reduces Albuminuria in Patients with Type 2 Diabetes

Murray Epstein, Gordon H. Williams, Myron H. Weinberger et al. · Clinical Journal of the American Society of Nephrology · 2006 · 453 citations

Combination of Empagliflozin and Linagliptin as Second-Line Therapy in Subjects With Type 2 Diabetes Inadequately Controlled on Metformin

Ralph A. DeFronzo, Andrew Lewin, Sanjay Patel et al. · Diabetes Care · 2015 · 284 citations

Rows per page

1–5 of 41